GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,769.50p
   
  • Change Today:
      34.00p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,620.00
  • Currency: UK Pounds
  • Shares Issued: 4,045.43m
  • Volume: 1,268,536
  • Market Cap: £71,584m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

Berenberg upgrades GSK to 'buy', raises target price

By Iain Gilbert

Date: Tuesday 15 Sep 2026

(Sharecast News) - Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from £20 to £22, saying recent business‑development activity and pipeline momentum had strengthened the firm's long‑term growth outlook and left its valuation discount looking excessive.

GSK ShareCast News

GSK acquires global rights to multiple myeloma a... 15-Sep-2026 ShareCast
GSK highlights pipeline momentum with Ris‑... 14-Sep-2026 ShareCast
GSK gets Japanese approval for new ready‑t... 10-Sep-2026 ShareCast
GSK advances mRNA flu shot after Phase II success 01-Sep-2026 ShareCast
GSK notches major regulatory milestones in Japan... 24-Aug-2026 ShareCast

GSK Regulatory News

Wendy Becker CBE - New Directorship 08-Oct-2026 15:00 RNS
Admission to Trading 06-Oct-2026 15:00 RNS
Total Voting Rights 01-Oct-2026 15:00 RNS
Director/PDMR Shareholding 24-Sep-2026 15:30 RNS
Director/PDMR Shareholding 22-Sep-2026 15:30 RNS

GSK Newspaper Links

GSK invests £400m to relocate research headquart... 28-Jul-2026 Times
GSK to buy US cancer treatment firm Nuvalent for... 09-Jun-2026 Guardian
GSK signs £45m deal with UCL offshoot for liver ... 08-Jun-2026 Times
Strong vaccine sales deliver an early boost for ... 29-Apr-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,769.50p
Change Today 34.00p
% Change 1.96 %
52 Week High 2,208.00
52 Week Low 1,620.00
Volume 1,268,536
Shares Issued 4,045.43m
Market Cap £71,584m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.16% below the market average75.16% below the market average75.16% below the market average75.16% below the market average75.16% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average
Price Trend
75.14% above the market average75.14% above the market average75.14% above the market average75.14% above the market average75.14% above the market average
72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average
Income
24.36% above the market average24.36% above the market average24.36% above the market average24.36% above the market average24.36% above the market average
Sector averageSector averageSector averageSector averageSector average
Growth
39.77% above the market average39.77% above the market average39.77% above the market average39.77% above the market average39.77% above the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 12
Sell 2
Strong Sell 0
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 13-Aug-26 14-May-26
Paid 08-Oct-26 09-Jul-26
Amount 17.00p 17.00p

Trades for 09-Oct-2026

Time Volume / Share Price
13:10 283 @ 1,769.50p
13:10 438 @ 1,769.50p
13:10 76 @ 1,768.50p
13:09 0 @ 1,768.50p
13:09 154 @ 1,768.00p

GSK Key Personnel

CEO Luke Miels

Top of Page